Search
for
Sort by
Research 61–90 of 1000+
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- New and Emerging Therapies for Alopecia Areata
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- Immune therapies for alopecia areata: evidence and new perspectives
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- CXCL12 inhibits hair growth through CXCR4
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Resident Memory T Cells in Autoimmune Skin Diseases
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives